Advyzon Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.48M Buy
20,654
+1,565
+8% +$181K 0.22% 107
2025
Q4
$2.01M Buy
19,089
+6,883
+56% +$646K 0.23% 104
2025
Q3
$1.02M Buy
12,206
+3,073
+34% +$253K 0.18% 125
2025
Q2
$723K Buy
9,133
+453
+5% +$36K 0.16% 127
2025
Q1
$779K Buy
8,680
+1,248
+17% +$117K 0.28% 73
2024
Q4
$739K Buy
+7,432
New +$766K 0.29% 71

Other funds holding MRK

Advyzon Investment Management's MRK Position: Q1 2026 in Review

Advyzon Investment Management increased its Merck (MRK) stake by 8.2% in Q1 2026, buying an estimated $181K and bringing the position to 20,654 shares worth $2.48M. The position accounts for 0.22% of the portfolio, ranked #107.

Advyzon Investment Management first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Advyzon Investment Management held 20,654 shares of Merck worth $2.48M as of Q1 2026.
  • Advyzon Investment Management bought 1,565 Merck shares in Q1 2026, an estimated $181K.
  • Merck made up 0.22% of Advyzon Investment Management's portfolio in Q1 2026, its #107 holding.
  • Advyzon Investment Management first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Advyzon Investment Management's 13F filing for Q1 2026, filed 12 May 2026.